- Dose range
- 200-600 mg IV / 2 g IM
- Route
- IV, IM, oral, or topical
- Indication(s)
- Antioxidant; skin lightening (off-label); detox protocols
Titration schedule
| Step | Dose | Duration | Notes |
|---|---|---|---|
| - | 200-600 mg IV / 2 g IM | Weekly or 2-3×/week | Or oral 500-1500 mg |
Important notes
- This research compound dosing chart is intended as a reference for clinicians and patients reviewing protocols, not a substitute for individualized prescriber guidance.
- Research compound; not FDA-approved for any indication. Off-label or experimental use only.
- Compounded versions, where applicable, must be prepared by a licensed 503A or 503B compounding pharmacy. The April 14, 2026 FDA action restricted salt-form active ingredients.
References
- Glutathione (GSH) prescribing information / clinical literature.
- FDA Section 503A Interim Bulk Drug Substances List, updated April 14, 2026.
- USP <797>: Pharmaceutical Compounding — Sterile Preparations.